• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    5.23 Down 0.05(0.95%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:5.28
    Open:5.25
    Bid:4.75 x 300
    Ask:N/A
    1y Target Est:11.00
    Beta:0.92
    Next Earnings Date: 4-Mar-15ALIM Earnings announcement
    Day's Range:5.11 - 5.36
    52wk Range:4.58 - 8.36
    Volume:155,234
    Avg Vol (3m):177,852
    Market Cap:231.67M
    P/E (ttm):N/A
    EPS (ttm):-1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIMDown 0.95%231.67M
    AGNUp 0.15%69.88B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):30.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback